San Francisco Dental Artistry in San Francisco, California

Info
Map & Directions
  • No Records Found

    Sorry, no records were found. Please adjust your search criteria and try again.

    Google Map Not Loaded

    Sorry, unable to load Google Maps API.

  • San Francisco Dental Artistry

  • San Francisco Dental Artistry

  • Evangeline Amores DDS

  • Dr. Maya Eydelman

  • Digital Dental Practice San Francisco Dentist

  • Digital Dental Practice San Francisco Dentist

  • Aurora Bay Area Prices – REP DEV, URINARY, W/SLING is $3,440.68

    At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10006027, regarding REP DEV, URINARY, W/SLING, which is classified under revenue code 278 and associated with CPT code C1771, the designated fee stands at $3,440.68. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • Aurora Sheboygan Prices – NMO AQUAPORIN 4 AB TITER is $505

    At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10006106, regarding NMO AQUAPORIN 4 AB TITER, which is classified under revenue code 302 and associated with CPT code 86256, the designated fee stands at $505. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • |
    New Vaccines in 2025: Latest Developments You Should Know About

    New Vaccines in 2025: Latest Developments You Should Know About offers a clear, patient-centered overview of what’s new and why it matters. It highlights this year’s updates to COVID‑19 and flu vaccines, the growing availability of RSV protection for infants, pregnant people, and older adults, and broader coverage options for pneumococcal and meningococcal disease in certain groups. The article explains how newer platforms (such as mRNA and protein-based vaccines) may improve protection and convenience, outlines typical side effects and safety monitoring, and shares tips on timing shots with other care. It also points you to trustworthy resources (CDC, WHO, your clinician) and coverage options so you can make confident, evidence-based vaccination decisions.